🔗 Share this article

A shadow economy for unlicensed weight-loss medications is being driven by TikTok fitness influencers and vendors on communication apps, according to new investigations.

Experimental Drug Acquiring Traction Via Social Media

Retatrutide, which remains in clinical trials, is being advertised by social media influencers for its alleged fat-burning effects. Followers are urged to message these profiles privately for supplier links, while also receiving promotional offers.

Thriving Trade on Messaging Platforms

Separately, a flourishing trade exists on messaging services, where groups with numerous of participants share “before and after” images, administration instructions and assertions of rapid British shipping. Vendors promote the substance there before redirecting buyers to WhatsApp for purchases.

Understanding Retatrutide

Retatrutide is an investigational injection created by US drugmaker Eli Lilly. The drug affects three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could help individuals lose up to a quarter of their total weight. Referred to as the “triple G”, the drug is being hailed online as the successor to Ozempic.

Medical Experts Voice Worries

However, doctors and pharmacists have warned that the sale of what remains an unapproved drug in the UK is a cause for concern and could result in individuals injecting products of uncertain source.

Several experts said the popularity for retatrutide could be linked to the increasing cost of licensed slimming treatments such as Mounjaro.

Regulatory Status and Enforcement

Marketing retatrutide on TikTok or messaging apps is illegal in the United Kingdom, as it is an unlicensed medication that cannot be promoted or supplied for human use under the British medical regulations.

Some influencers attempt to sidestep the regulations by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but advertising and distribution can still violate pharmaceutical, marketing, and customer laws, potentially leading to penalties, legal action or imprisonment.

Service Response and Content Elimination

Based on TikTok, the platform has removed problematic content and banned related keywords and search suggestions. The organization said it was committed to maintaining the platform secure and investing in enhancing enforcement strategies.

Online Trading Operations

Investigations also found groups with up to 9,000 participants selling retatrutide using the platform's built-in discovery tool, which operates like a public directory. Typing “retatrutide” immediately brings up channels with thousands of users, populated with photos of weight loss, positive testimonials and detailed guides for mixing or injecting at home.

Within minutes of joining one group, a seller shared WhatsApp details, where the majority of transactions take place. The seller provided an instruction manual and promised delivery within two days. When questioned whether the product was authentic, one seller responded: “You can’t be sure.” Another shared a photo of a alleged laboratory certificate. None asked about body mass, health issues or previous experience.

Item Details and Pricing

Within these communities, posts display black plastic packages with Royal Mail stickers, claiming to include new batches. One message stated: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, prepared at home with sterile water, or ready-to-use pens usually priced at £160 for 20 milligrams. When questioned how much time a injector should be used, vendors give contradictory answers varying between a several days to “depends on your body”.

Service Oversight and Security Actions

A representative for Telegram stated it regularly monitored dangerous content on its platform including material that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“People are administering materials they can’t verify. Even if the science behind retatrutide is valid, these digital products may not include what they claim,” said Jason Murphy, the head of pharmaceutical services at Chemist4U.

A medical professional of Asda Online Doctor linked the increase in interest to recent cost increases for authorized slimming drugs such as Mounjaro. “With costs increasing, patients are using social media. But counterfeit treatments are extremely risky. You cannot know what’s inside or whether the conditions they were produced in was sterile,” she said.

Her staff has already encountered patients injured by self-injection from unconfirmed suppliers. “We understand the disappointment, but buying from Telegram or communication platforms is taking chances with your health,” stated Wyllie. “These substances could be impure or incorrectly dosed.”

Manufacturer Statement

A spokesperson from the pharmaceutical company said the substance was in phase 3 clinical trials and had not been reviewed or approved by any regulatory agency anywhere in the world. “Therefore at this time no one can sell [it] for personal consumption,” they said, adding that any product “falsely representing itself as a company investigational substance not yet approved … may expose users to potentially significant medical dangers”.